Ann: Trading Halt Request, page-26

"According to the chairman on 19th October 2017
As previously reported FDA approval is expected to be in the early part of 2018 ....."

That was back when Alan Hoffman and Co were directors.
I have a suspicion that one reason for all the disputes related in part to faulty communication or understanding of when FDA approval would commence or be granted.

There were obviously other factors too, but finding out that FDA approval hadn't even commenced when you were announcing it would be received could lead to real antagonism I would have thought.